These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19560398)

  • 1. Measurements of HCV neutralizing antibodies and of HCV-specific CD4+ and CD8+ cells using hepatitis C virus pseudo-particles (HCVpp).
    Berger A; Giroglou T; Leutz A; Ogbomo H; Pfaff K; Teuber G; Cinatl J; van Laer D; Doerr HW
    J Clin Virol; 2009 Sep; 46(1):55-60. PubMed ID: 19560398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection.
    van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D
    J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of neutralizing antibodies with HCV pseudoparticles (HCVpp).
    Dreux M; Cosset FL
    Methods Mol Biol; 2009; 510():427-38. PubMed ID: 19009280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection.
    Rico MA; Ruiz S; Subirá D; Barril G; Cigarrán S; Castañón S; Quiroga JA; Selgas R; Carreño V
    J Med Virol; 2004 Jan; 72(1):66-74. PubMed ID: 14635013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.
    Krishnadas DK; Li W; Kumar R; Tyrrell LJ; Agrawal B
    Cell Immunol; 2009; 259(2):141-9. PubMed ID: 19616202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies.
    Fournier C; Duverlie G; François C; Schnuriger A; Dedeurwaerder S; Brochot E; Capron D; Wychowski C; Thibault V; Castelain S
    Virol J; 2007 Mar; 4():35. PubMed ID: 17397531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C.
    Kaplan DE; Sugimoto K; Newton K; Valiga ME; Ikeda F; Aytaman A; Nunes FA; Lucey MR; Vance BA; Vonderheide RH; Reddy KR; McKeating JA; Chang KM
    Gastroenterology; 2007 Feb; 132(2):654-66. PubMed ID: 17258733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus-specific CD4+ T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease.
    Schirren CA; Jung MC; Worzfeld T; Mamin M; Baretton G; Gerlach JT; Gruener NH; Zachoval R; Houghton M; Rau HG; Pape GR
    J Infect Dis; 2001 Apr; 183(8):1187-94. PubMed ID: 11262200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the role of neutralizing antibodies against envelope genes in resolving HCV pseudo-particles infection.
    Rafique S; Idrees M; Ali A; Iqbal M
    Mol Biol Rep; 2014 Jun; 41(6):3945-50. PubMed ID: 24566682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses.
    Urbani S; Amadei B; Fisicaro P; Tola D; Orlandini A; Sacchelli L; Mori C; Missale G; Ferrari C
    Hepatology; 2006 Jul; 44(1):126-39. PubMed ID: 16799989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low levels of hepatitis C virus (HCV) neutralizing antibodies in patients coinfected with HCV and human immunodeficiency virus.
    Castelain S; Schnuriger A; François C; Nguyen-Khac E; Fournier C; Schmit JL; Capron D; Dubuisson J; Wychowski C; Thibault V; Duverlie G
    J Infect Dis; 2008 Aug; 198(3):332-5. PubMed ID: 18558868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.
    Heeg MH; Ulsenheimer A; Grüner NH; Zachoval R; Jung MC; Gerlach JT; Raziorrouh B; Schraut W; Horster S; Kauke T; Spannagl M; Diepolder HM
    Gastroenterology; 2009 Oct; 137(4):1280-8.e1-6. PubMed ID: 19596013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection.
    Jeong HY; Lee YJ; Seo SK; Lee SW; Park SJ; Lee JN; Sohn HS; Yao S; Chen L; Choi I
    J Leukoc Biol; 2008 Mar; 83(3):755-64. PubMed ID: 18086898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardized Method for the Study of Antibody Neutralization of HCV Pseudoparticles (HCVpp).
    Bailey JR; Urbanowicz RA; Ball JK; Law M; Foung SKH
    Methods Mol Biol; 2019; 1911():441-450. PubMed ID: 30593644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design.
    Smyk-Pearson S; Tester IA; Lezotte D; Sasaki AW; Lewinsohn DM; Rosen HR
    J Infect Dis; 2006 Aug; 194(4):454-63. PubMed ID: 16845628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of infectious pseudo-particle harboring three subtypes hepatitis C virus glycoproteins and their application in neutralization assays].
    Zhang K; Tan WJ; Deng Y; Li J; Wu XB; Ruan L
    Bing Du Xue Bao; 2008 Jul; 24(4):287-94. PubMed ID: 18780632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women.
    Della Bella S; Riva A; Tanzi E; Nicola S; Amendola A; Vecchi L; Nebbia G; Longhi R; Zanetti AR; Villa ML
    J Hepatol; 2005 Sep; 43(3):394-402. PubMed ID: 16023248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage?
    Godkin A; Ng WF; Gallagher K; Betts G; Thomas HC; Lechler RI
    J Allergy Clin Immunol; 2008 May; 121(5):1277-1284.e3. PubMed ID: 18355912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variability.
    Weseslindtner L; Neumann-Haefelin C; Viazov S; Haberstroh A; Kletzmayr J; Aberle JH; Timm J; Ross SR; Klauser-Braun R; Baumert TF; Roggendorf M; Thimme R; Holzmann H
    J Hepatol; 2009 Apr; 50(4):693-704. PubMed ID: 19231006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.
    von Hahn T; Yoon JC; Alter H; Rice CM; Rehermann B; Balfe P; McKeating JA
    Gastroenterology; 2007 Feb; 132(2):667-78. PubMed ID: 17258731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.